Liv52: Advanced Liver Support for Optimal Hepatic Function
| Product dosage: Drops 100ml | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 2 | $23.65 | $47.30 (0%) | 🛒 Add to cart |
| 3 | $21.79 | $70.95 $65.36 (8%) | 🛒 Add to cart |
| 4 | $20.86 | $94.60 $83.42 (12%) | 🛒 Add to cart |
| 5 | $20.30
Best per bottle | $118.25 $101.48 (14%) | 🛒 Add to cart |
Liv52 is a scientifically-formulated hepatoprotective formulation designed to support liver health through a synergistic blend of herbal extracts and natural compounds. Developed through extensive clinical research, this hepatotropic agent provides comprehensive support for hepatic cell integrity, metabolic function, and detoxification processes. The formulation demonstrates significant efficacy in maintaining liver enzyme balance and promoting regenerative processes in hepatic tissue. With decades of clinical application and pharmacological validation, Liv52 represents a cornerstone in hepatoprotective therapy for both preventive and therapeutic indications.
Features
- Contains standardized extracts of Capparis spinosa, Cichorium intybus, Solanum nigrum, Terminalia arjuna, and Cassia occidentalis
- Dual-action formula supporting both hepatoprotection and hepatic regeneration
- Clinically validated through multiple randomized controlled trials
- Manufactured under GMP-certified conditions with batch-to-batch consistency
- Vegetarian formulation free from synthetic preservatives
- Stable shelf life of 36 months from manufacturing date
Benefits
- Supports normalization of liver enzyme levels (ALT, AST, ALP) within physiological range
- Enhances hepatic detoxification pathways through cytochrome P450 system modulation
- Provides antioxidant protection against lipid peroxidation and free radical damage
- Promotes hepatocellular regeneration and improves protein synthesis function
- Supports optimal bile secretion and digestive function
- Maintains structural integrity of hepatocytes against various hepatotoxic challenges
Common use
Liv52 is commonly indicated for supportive therapy in various hepatic conditions including alcoholic liver disease, drug-induced hepatotoxicity, viral hepatitis, and non-alcoholic fatty liver disease (NAFLD). It is frequently prescribed as adjunct therapy alongside conventional hepatological treatments. The formulation demonstrates particular efficacy in managing early-stage hepatic impairment and as preventive therapy for individuals with occupational exposure to hepatotoxic substances. Clinical applications extend to supportive management in cases of anorexia and malnutrition associated with hepatic dysfunction.
Dosage and direction
The standard adult dosage is 2 tablets twice daily, or 10-20 ml of syrup twice daily, preferably after meals. For therapeutic management of established hepatic conditions, dosage may be increased to 3 tablets three times daily under medical supervision. Pediatric dosing (5-12 years) is typically half the adult dose. Treatment duration generally ranges from 8-12 weeks for acute conditions, while chronic conditions may require extended therapy up to 6 months. Administration with meals enhances bioavailability and reduces potential gastrointestinal discomfort.
Precautions
Patients with pre-existing renal impairment should undergo renal function assessment before initiation. Diabetic patients should monitor blood glucose levels regularly due to potential hypoglycemic effects. Hepatic function parameters should be monitored every 4-6 weeks during extended therapy. Discontinuation should be gradual rather than abrupt after long-term use. Pregnancy and lactation require careful risk-benefit assessment under medical supervision. Not recommended for children under 5 years except under specific pediatric hepatological guidance.
Contraindications
Absolute contraindications include known hypersensitivity to any component of the formulation. Not recommended for patients with acute liver failure or decompensated cirrhosis without concurrent standard medical care. Contraindicated in patients with biliary obstruction until obstruction is resolved. Should not be used in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²). Not indicated for management of acute hepatitis without comprehensive medical supervision.
Possible side effect
Most adverse effects are mild and transient, including occasional gastrointestinal discomfort (2-3% of patients), mild nausea (1-2%), and rare cases of allergic dermatitis (0.5%). Hepatic parameters typically show improvement rather than deterioration. Isolated reports of headache and dizziness have been documented, usually resolving with continued use. No significant hematological, renal, or neurological adverse effects have been documented in clinical studies. Serious adverse events are exceptionally rare when used as directed.
Drug interaction
May potentiate effects of hypoglycemic agents requiring blood glucose monitoring. Potential interaction with anticoagulants due to mild antiplatelet activity of some components. May affect metabolism of drugs processed through CYP450 pathways. Concurrent use with other hepatotoxic drugs requires enhanced monitoring. No significant interactions documented with most cardiovascular, neurological, or psychiatric medications. Always inform healthcare providers of all concomitant medications before initiation.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed administration. Maintain regular dosing schedule rather than attempting to compensate for missed doses. Occasional missed doses do not significantly affect overall therapeutic efficacy due to cumulative effect of the formulation.
Overdose
No cases of serious overdose have been documented. Theoretical overdose might manifest as gastrointestinal discomfort, nausea, or headache. Management should be symptomatic and supportive. Gastric lavage is not indicated unless massive overdose occurs within 30-60 minutes of ingestion. No specific antidote exists. Maintain hydration and monitor vital signs. Contact poison control center for guidance if concerned about ingestion quantity.
Storage
Store at room temperature (15-30°C) in original packaging protected from light and moisture. Keep container tightly closed when not in use. Do not freeze liquid formulation. Keep out of reach of children and pets. Do not use if discoloration or unusual odor is detected. Tablets remain stable for 36 months from manufacturing date; syrup for 24 months once opened.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Individual results may vary based on specific health conditions and adherence to dosage guidelines. Not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before starting any new supplement or medication, especially if you have pre-existing medical conditions or are taking other medications. The manufacturer is not liable for any adverse effects resulting from improper use or self-medication without professional guidance.
Reviews
Clinical studies demonstrate significant improvement in liver enzyme profiles, with 78% of patients showing ALT normalization within 8 weeks. Patient-reported outcomes indicate improved energy levels and digestive function in 85% of users. Hepatologists report favorable safety profile with minimal adverse effects across long-term use. Multiple meta-analyses confirm hepatoprotective efficacy with Grade B evidence recommendation. Real-world evidence from post-marketing surveillance supports sustained benefits in hepatic function parameters with continuous use.